193 related articles for article (PubMed ID: 15674418)
1. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
[TBL] [Abstract][Full Text] [Related]
2. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
3. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
4. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
5. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
6. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
7. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
8. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
[TBL] [Abstract][Full Text] [Related]
9. New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells.
Eaves C; Jiang X; Eisterer W; Chalandon Y; Porada G; Zanjani E; Eaves A
Ann N Y Acad Sci; 2003 May; 996():1-9. PubMed ID: 12799276
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
Cashman JD; Eaves AC; Eaves CJ
Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.
Jiang X; Zhao Y; Smith C; Gasparetto M; Turhan A; Eaves A; Eaves C
Leukemia; 2007 May; 21(5):926-35. PubMed ID: 17330101
[TBL] [Abstract][Full Text] [Related]
12. Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation.
Dazzi F; Hasserjian R; Gordon MY; Boecklin F; Cotter F; Corbo M; Capelli D; Goldman JM
Hematol J; 2000; 1(5):307-15. PubMed ID: 11920208
[TBL] [Abstract][Full Text] [Related]
13. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
[TBL] [Abstract][Full Text] [Related]
15. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Pilarski LM; Belch AR
Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.
Holyoake T; Jiang X; Eaves C; Eaves A
Blood; 1999 Sep; 94(6):2056-64. PubMed ID: 10477735
[TBL] [Abstract][Full Text] [Related]
17. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration.
Nicolini FE; Cashman JD; Hogge DE; Humphries RK; Eaves CJ
Leukemia; 2004 Feb; 18(2):341-7. PubMed ID: 14628073
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice.
Chalandon Y; Jiang X; Christ O; Loutet S; Thanopoulou E; Eaves A; Eaves C
Leukemia; 2005 Mar; 19(3):442-8. PubMed ID: 15674417
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia.
Sloma I; Beer PA; Saw KM; Chan M; Leung D; Raghuram K; Brimacombe C; Johnston B; Lambie K; Forrest D; Jiang X; Eaves CJ
Exp Hematol; 2013 Oct; 41(10):837-47. PubMed ID: 23851302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]